Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-14 to 2026-02-13
Current total value of award: $23478.06
Description: THIS IS FOR CLINICAL RESEARCH STUDY CRISPR-BASED GENOME EDITING SERVICE TO GENERATE PC12 CELL LINES WITH SNAP AND HALO-TAG SINSERTED AT ENDOGENOUS LOCI OF VAMP2 AND SYNTAXIN1A. INCLUDES GUIDE RNA DESIGN, DONOR SYNTHESIS, TRANSFECTION, CLONAL SCREENIN